SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZMO

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jeffbas who wrote (417)1/6/2002 7:36:58 PM
From: Spekulatius   of 438
 
<< ExtraPale, my background is finance - note this post of mine from Yahoo which puts a little additional perspective on the $32M deal.>>
Agreed, this is a very good deal for GZMO. ALso note that this is the second time that GENZ helped GZMO. GENZ bought a secondary from GZMO in 2000 , at prices above market value (it was something like the 30 day average stock price ).
I think that GENZ really wants GZMO to succeed, but at the same time they acknowledge that its high risk stuff and don't want to see the R&D on their on balance sheet.
I would tend to be at the buyers side, but the obvious lack of progress for GZMO's business plan make me much more cautious than I have been last year.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext